Results 241 to 250 of about 227,935 (279)

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source

Identifying essential medications for critical care: initial findings from US academic intensive care units. [PDF]

J Pharm Policy Pract
Wireko FW, Miller A, Touray S, Sefa N.
europepmc   +1 more source

Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines: the Sexual and Reproductive Health Context [PDF]

, 2008
Hunt, PH, Khosla, R
core  

Availability and affordability of essential medicines in African low- and middle-income countries: a systematic review and meta-analysis (2014-2025). [PDF]

BMC Public Health
Albagir HA.
europepmc   +1 more source

The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal Health. [PDF]

Arthritis Res Ther
Scott C, Slamang W, Dushnicky M, Hause E, Faleye A, Furia F, Cuevas OA, Hadef D, Munro J, Nzabonimpa C, Foster H, Migowa A, Paediatric Global Task Force for Musculoskeletal Health.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The interpretation of China national essential medicines list 2018

Expert Review of Clinical Pharmacology, 2020
Background: In 2018, China implemented the latest National Essential Medicines List (NEML) by enhancing the NEML 2012. The goal of our studies is to analyze the changes in the two lists and compared them with the 20th EML issued by WHO in 2017. And then provide suggestions for emerging problems.Method: The overall composition of the categories ...
Wei, Zuo, Dan, Mei, Wenjuan, Sun, Xiaowan, Tang, Ziran, Niu, Daihui, Gao, Bo, Zhang   +6 more
openaire   +4 more sources

Anticancer medicines in Pakistan: An analysis of essential medicines lists

Journal of Oncology Pharmacy Practice, 2023
Objective The lack of anticancer drugs for curative and supportive purposes is the critical reason for the low survival rate in low-and-middle-income countries. This study aims to analyze whether the National Essential Medicines List (NEML) and Registered Essential Medicines List (REML) are in concordance with the World Health Organization (WHO ...
Sundus Shukar, Rehan Anjum, Jinwei Zhang, Zaheer-Ud-Din Babar, Iqra Mobeen, Caijun Yang   +5 more
openaire   +2 more sources

The Essential Medicines List for a Global Patient Population

Clinical Pharmacology & Therapeutics, 2007
Thirty years after its inception, the role, audience, and contents of the global Essential Medicines List (EML) are reviewed. Challenges for decision makers in applying the principles of medicine selection based on efficacy, safety, burden of disease, and cost effectiveness are discussed and illustrated with recent decisions of the Expert Committee ...
J, Robertson, S R, Hill
openaire   +2 more sources